BONDOC ȘI ASOCIAȚII advised BFS Molecular, a software company focusing on next-generation sequencing-based patient testing solutions, in a transaction concerning the sale of its assets
BONDOC ȘI ASOCIAȚII advised BFS Molecular, a software company focusing on next-generation sequencing-based patient testing solutions, in a transaction concerning the sale of its assets, including intellectual property, to a leading precision medicine company acting in the field of solutions… Read moreBONDOC ȘI ASOCIAȚII advised BFS Molecular, a software company focusing on next-generation sequencing-based patient testing solutions, in a transaction concerning the sale of its assets
